For some patients with breast cancer, neoadjuvant chemotherapy may allow them to forego regional nodal irradiation.

Published Date: 17 Jan 2024

The risk of disease recurrence was not increased in patients whose breast cancer, following neoadjuvant chemotherapy, changed from lymph node-positive to lymph node-negative after not receiving adjuvant regional nodal irradiation (RNI).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Boom in ADHD Coaching Has Few Rules

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot